DEXILANT
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $25,719 | 124 | 70 |
| 2020 | $6,348 | 26 | 21 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,220 | 6 | 50.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,465 | 3 | 38.9% |
| Food and Beverage | $2,097 | 138 | 6.5% |
| Unspecified | $1,260 | 2 | 3.9% |
| Travel and Lodging | $25.00 | 1 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A PHASE 2, DOUBLE BLIND, UP TO 40 WEEK, MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF DAILY ORAL ADMINISTRATION OF DEXLANSOPRAZOLE DELAYED-RELEASE CAPSULES FOR HEALING OF EROSIVE ESOPHAGITIS (EE) AND MAINTENANCE OF HEALED EE IN PEDIATRIC SUBJECTS AGED 1 TO 11 YEARS WITH EE | Takeda Pharmaceuticals U.S.A., Inc. | $630.00 | 0 |
| A PHASE 2, DOUBLE-BLIND, 12 WEEK, MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF DAILY ORAL ADMINISTRATION OF DEXLANSOPRAZOLE DELAYED-RELEASE CAPSULES IN PEDIATRIC SUBJECTS AGED 1 TO 11 YEARS WITH SYMPTOMATIC NONEROSIVE GASTROESOPHAGEAL REFLUX DISEASE | Takeda Pharmaceuticals U.S.A., Inc. | $630.00 | 0 |
Top Doctors Receiving Payments for DEXILANT — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Otolaryngology | West Des Moines, IA | $25.73 | 2 |
| , D.O | Sports Medicine | Garden Grove, CA | $25.62 | 1 |
| , PA-C | Physician Assistant | Chesapeake, VA | $24.89 | 1 |
| , MD | Specialist | Bowling Green, KY | $24.71 | 1 |
| , M.D | Allergy & Immunology | Wilmington, NC | $24.67 | 1 |
| , M.D | Allergy & Immunology | Wilmington, NC | $24.67 | 1 |
| Brian Grossman | Primary Care | Allen Park, MI | $24.07 | 1 |
| , M.D | Internal Medicine | Oak Brook, IL | $23.98 | 1 |
| , M.D | Internal Medicine | Oak Brook, IL | $23.98 | 1 |
| , M.D | Allergy & Immunology | Plano, TX | $22.67 | 1 |
| , P.A.-C | Physician Assistant | Plano, TX | $22.67 | 1 |
| , MD | Gastroenterology | Orlando, FL | $21.27 | 1 |
| , DO | Gastroenterology | Orlando, FL | $21.27 | 1 |
| , M.D | Specialist | Greenfield, WI | $21.10 | 1 |
| Thejaswi Bandikatla | Student in an Organized Health Care Education/Training Program | Maitland, FL | $21.05 | 1 |
| , ARNP | Adult Health | Orlando, FL | $21.05 | 1 |
| , M.D | Internal Medicine | Houston, TX | $20.31 | 2 |
| , FNP- BC | Primary Care | Mesa, AZ | $18.93 | 1 |
| , NP | Family Medicine | Mesa, AZ | $18.93 | 1 |
| , M.D | Pediatric Gastroenterology | Mesa, AZ | $18.93 | 1 |
| , FNP-BC | Family | Mesa, AZ | $18.93 | 1 |
| , AGACNP | Acute Care | Mesa, AZ | $18.93 | 1 |
| , D.O | Family Medicine | Overland Park, KS | $18.73 | 1 |
| , M.D | Specialist | Sugar Land, TX | $18.27 | 1 |
| , MD | Allergy | Joliet, IL | $17.94 | 1 |
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $32,067
- Total Doctors 88
- Transactions 150
About DEXILANT
DEXILANT is a drug associated with $32,067 in payments to 88 healthcare providers, recorded across 150 transactions in the CMS Open Payments database. The primary manufacturer is Takeda Pharmaceuticals U.S.A., Inc..
Payment data is available from 2020 to 2021. In 2021, $25,719 was paid across 124 transactions to 70 doctors.
The most common payment nature for DEXILANT is "Consulting Fee" ($16,220, 50.6% of total).
DEXILANT is associated with 2 research studies, including "A PHASE 2, DOUBLE BLIND, UP TO 40 WEEK, MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF DAILY ORAL ADMINISTRATION OF DEXLANSOPRAZOLE DELAYED-RELEASE CAPSULES FOR HEALING OF EROSIVE ESOPHAGITIS (EE) AND MAINTENANCE OF HEALED EE IN PEDIATRIC SUBJECTS AGED 1 TO 11 YEARS WITH EE" ($630.00).